Hruban RH - Search Results

1

The prevalence of BRCA2 mutations in familial pancreatic cancer.

Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M, Rothenmund H, Gallinger S, Klein A, Petersen GM, Hruban RH. Couch FJ, et al. Among authors: hruban rh. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):342-6. doi: 10.1158/1055-9965.EPI-06-0783. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17301269

2

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE. Redston MS, et al. Among authors: hruban rh. Cancer Res. 1994 Jun 1;54(11):3025-33. Cancer Res. 1994. PMID: 8187092

3

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE. Goggins M, et al. Among authors: hruban rh. Cancer Res. 1996 Dec 1;56(23):5360-4. Cancer Res. 1996. PMID: 8968085

4

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. Rozenblum E, et al. Among authors: hruban rh. Cancer Res. 1997 May 1;57(9):1731-4. Cancer Res. 1997. PMID: 9135016

5

p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Moskaluk CA, Hruban RH, Kern SE. Moskaluk CA, et al. Among authors: hruban rh. Cancer Res. 1997 Jun 1;57(11):2140-3. Cancer Res. 1997. PMID: 9187111

6

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.

Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH, Slebos RJ. Wilentz RE, et al. Among authors: hruban rh. Cancer. 1998 Jan 1;82(1):96-103. doi: 10.1002/(sici)1097-0142(19980101)82:1<96::aid-cncr11>3.0.co;2-8. Cancer. 1998. PMID: 9428484

7

Genetics of pancreatic cancer. From genes to families.

Hruban RH, Petersen GM, Ha PK, Kern SE. Hruban RH, et al. Surg Oncol Clin N Am. 1998 Jan;7(1):1-23. Surg Oncol Clin N Am. 1998. PMID: 9443984 Review.

8

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, Sohn TA, Yeo CJ, Kern SE, Hruban RH. Goggins M, et al. Among authors: hruban rh. Am J Pathol. 1998 Jun;152(6):1501-7. Am J Pathol. 1998. PMID: 9626054 Free PMC article.

9

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH. Wilentz RE, et al. Among authors: hruban rh. Cancer Res. 1998 Oct 15;58(20):4740-4. Cancer Res. 1998. PMID: 9788631

10

Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE. Goggins M, et al. Among authors: hruban rh. Cancer Res. 1998 Dec 1;58(23):5329-32. Cancer Res. 1998. PMID: 9850059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,060 results

Search Page